BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35403930)

  • 1. Hereditary breast cancer and fertility preservation outcomes.
    Arab S; Tulandi T; Buckett W
    J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women.
    Volodarsky-Perel A; Cai E; Tulandi T; Son WY; Suarthana E; Buckett W
    Reprod Biomed Online; 2020 Feb; 40(2):215-222. PubMed ID: 31953011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
    Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
    Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
    Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
    Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer grade and stage do not affect fertility preservation outcomes.
    Wald K; Wang A; Abel MK; Morris J; Letourneau JM; Mok-Lin E; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2022 May; 39(5):1155-1161. PubMed ID: 35320444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation among young breast cancer patients: A single-center experience in China.
    Wan Q; Han L; Liu J; Li H; Li Y; Long QM; Tan L; Li JJ
    Taiwan J Obstet Gynecol; 2021 Sep; 60(5):827-830. PubMed ID: 34507656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases.
    Saito S; Yamada M; Yano R; Takahashi K; Ebara A; Sakanaka H; Matsumoto M; Ishimaru T; Utsuno H; Matsuzawa Y; Ooka R; Fukuoka M; Akashi K; Kamijo S; Hamatani T; Tanaka M
    J Ovarian Res; 2023 Aug; 16(1):159. PubMed ID: 37563616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.
    Pereira N; Kelly AG; Stone LD; Witzke JD; Lekovich JP; Elias RT; Schattman GL; Rosenwaks Z
    Fertil Steril; 2017 Sep; 108(3):532-538. PubMed ID: 28865552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation.
    Oktay K; Buyuk E; Rodriguez-Wallberg KA; Sahin G
    Reprod Biomed Online; 2010 May; 20(5):634-8. PubMed ID: 20219430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
    Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
    J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.